Trial Profile
Phase 2 study of interferon alpha [Roferon] and isotretinoin [Accutane] in patients with T-cell malignancies
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary) ; Isotretinoin (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 31 Aug 2005 New trial record.